Correlation Between Vaccinex and Bluejay Diagnostics
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Bluejay Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Bluejay Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Bluejay Diagnostics, you can compare the effects of market volatilities on Vaccinex and Bluejay Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Bluejay Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Bluejay Diagnostics.
Diversification Opportunities for Vaccinex and Bluejay Diagnostics
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Vaccinex and Bluejay is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Bluejay Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bluejay Diagnostics and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Bluejay Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bluejay Diagnostics has no effect on the direction of Vaccinex i.e., Vaccinex and Bluejay Diagnostics go up and down completely randomly.
Pair Corralation between Vaccinex and Bluejay Diagnostics
Given the investment horizon of 90 days Vaccinex is expected to generate 0.69 times more return on investment than Bluejay Diagnostics. However, Vaccinex is 1.46 times less risky than Bluejay Diagnostics. It trades about -0.07 of its potential returns per unit of risk. Bluejay Diagnostics is currently generating about -0.09 per unit of risk. If you would invest 15,529 in Vaccinex on August 24, 2024 and sell it today you would lose (15,167) from holding Vaccinex or give up 97.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vaccinex vs. Bluejay Diagnostics
Performance |
| Timeline |
| Vaccinex |
| Bluejay Diagnostics |
Vaccinex and Bluejay Diagnostics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaccinex and Bluejay Diagnostics
The main advantage of trading using opposite Vaccinex and Bluejay Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Bluejay Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluejay Diagnostics will offset losses from the drop in Bluejay Diagnostics' long position.| Vaccinex vs. Lyra Therapeutics | Vaccinex vs. Hookipa Pharma | Vaccinex vs. Cingulate Warrants | Vaccinex vs. SAB Biotherapeutics |
| Bluejay Diagnostics vs. Bone Biologics Corp | Bluejay Diagnostics vs. Nuwellis | Bluejay Diagnostics vs. Heart Test Laboratories | Bluejay Diagnostics vs. Tivic Health Systems |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |